Andrew M. Hau, Ph.D. - Publications

Affiliations: 
2013 Oregon State University, Corvallis, OR 
Area:
Pharmacology, Cell Biology, Molecular Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by mTORC2 in Bladder Cancer Cells. The American Journal of Pathology. PMID 31199921 DOI: 10.1016/J.Ajpath.2019.05.010  0.369
2017 Hau AM, Nakasaki M, Nakashima K, Krish G, Hansel DE. Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition. Urologic Oncology. PMID 28427860 DOI: 10.1016/J.Urolonc.2017.03.025  0.38
2016 Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2α Activity and Is Targetable by Pegylated Arginine Deiminase. The American Journal of Pathology. PMID 27979310 DOI: 10.1016/J.Ajpath.2016.09.004  0.384
2016 Hau AM, Leivo MZ, Gilder AS, Hu JJ, Gonias SL, Hansel DE. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cellular Signalling. PMID 27777073 DOI: 10.1016/J.Cellsig.2016.10.010  0.383
2016 Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology. PMID 26988652 DOI: 10.1016/J.Ajpath.2016.01.008  0.32
2016 Hau AM, Gilder A, Hu J, Gonias SL, Hansel DE. uPAR and mTORC2 as coupled targets for therapeutics development in bladder cancer. Journal of Clinical Oncology. 34: 447-447. DOI: 10.1200/Jco.2016.34.2_Suppl.447  0.352
2015 Serrill JD, Wan X, Hau AM, Jang HS, Coleman DJ, Indra AK, Alani AW, McPhail KL, Ishmael JE. Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts. Investigational New Drugs. PMID 26563191 DOI: 10.1007/S10637-015-0303-X  0.648
2015 Serrill JD, Tan M, Fotso S, Sikorska J, Kasanah N, Hau AM, McPhail KL, Santosa DA, Zabriskie TM, Mahmud T, Viollet B, Proteau PJ, Ishmael JE. Apoptolidins A and C activate AMPK in metabolically sensitive cell types and are mechanistically distinct from oligomycin A Biochemical Pharmacology. 93: 251-265. PMID 25511868 DOI: 10.1016/J.Bcp.2014.11.015  0.658
2015 Nabika R, Suyama TL, Hau AM, Misu R, Ohno H, Ishmael JE, McPhail KL, Oishi S, Fujii N. Synthesis and biological evaluation of the [d-MeAla(11)]-epimer of coibamide A. Bioorganic & Medicinal Chemistry Letters. 25: 302-6. PMID 25488840 DOI: 10.1016/J.Bmcl.2014.11.044  0.616
2015 Sahu D, Gupta S, Hau AM, Elson P, Bomalaski J, Boss GR, Hansel DE. Abstract 4712: Targeting the arginine-nitric oxide pathway to arrest development and progression of invasive bladder cancer Cancer Research. 75: 4712-4712. DOI: 10.1158/1538-7445.Am2015-4712  0.365
2014 Bajaj G, Hau AM, Hsu P, Gafken PR, Schimerlik MI, Ishmael JE. Identification of an atypical calcium-dependent calmodulin binding site on the C-terminal domain of GluN2A. Biochemical and Biophysical Research Communications. 444: 588-94. PMID 24491550 DOI: 10.1016/J.Bbrc.2014.01.111  0.658
2013 Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. Plos One. 8: e81081. PMID 24312263 DOI: 10.1371/Journal.Pone.0081081  0.356
2013 Hau AM, Greenwood JA, Löhr CV, Serrill JD, Proteau PJ, Ganley IG, McPhail KL, Ishmael JE. Coibamide A induces mTOR-independent autophagy and cell death in human glioblastoma cells. Plos One. 8: e65250. PMID 23762328 DOI: 10.1371/Journal.Pone.0065250  0.653
2013 Sikorska J, Hau AM, Anklin C, Parker-Nance S, Davies-Coleman MT, Ishmael JE, McPhail KL. Correction to Mandelalides A–D, Cytotoxic Macrolides from a New Lissoclinum Species of South African Tunicate The Journal of Organic Chemistry. 78: 2812-2812. DOI: 10.1021/Jo4002646  0.591
2012 Sikorska J, Hau AM, Anklin C, Parker-Nance S, Davies-Coleman MT, Ishmael JE, McPhail KL. Mandelalides A-D, cytotoxic macrolides from a new Lissoclinum species of South African tunicate. The Journal of Organic Chemistry. 77: 6066-75. PMID 22712890 DOI: 10.1021/Jo3008622  0.646
2011 Thornburg CC, Thimmaiah M, Shaala LA, Hau AM, Malmo JM, Ishmael JE, Youssef DT, McPhail KL. Cyclic depsipeptides, grassypeptolides D and E and Ibu-epidemethoxylyngbyastatin 3, from a Red Sea Leptolyngbya cyanobacterium. Journal of Natural Products. 74: 1677-85. PMID 21806012 DOI: 10.1021/Np200270D  0.634
2009 Bajaj G, Zhang Y, Schimerlik MI, Hau AM, Yang J, Filtz TM, Kioussi C, Ishmael JE. N-methyl-D-aspartate receptor subunits are non-myosin targets of myosin regulatory light chain. The Journal of Biological Chemistry. 284: 1252-66. PMID 18945678 DOI: 10.1074/Jbc.M801861200  0.664
Show low-probability matches.